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ABSTRACT 
Considerable evidence suggests that combinatorial action of dietary bioactive 
compounds may be useful to prevent or reduce senile features. Therefore, a 
synergistic multi-target approach in dietary intervention may be effective in 
slowing down the aging process and increase healthy aging. Functional foods 
and nutraceuticals can exert specific anti-aging benefits such as improvement 
in mitochondrial function or induce neuroprotective effects to counteract the 
deleterious consequences of oxidative stress. In this project, we evaluated a 
novel treatment strategy by combining two bioactive dietary constituents 
(resveratrol and equol) to determine their effect on mitochondrial function. 
The combined use of both compounds increased mitochondrial mass,  
mitochondrial DNA content, SIRT1 enzymatic activity and induced 
mitochondrial biogenesis factors such as PGC1-α, TFAM and NRF-1. 
Therefore, identification of this novel synergism may provide a new 
perspective for future treatments aiming to modulate the mitochondrial 
activity. Next, we investigated the combined effect of L-Carnosine and 
EGCG, two bioactive dietary compounds that have received particular 
attention because of their potential role in modulating oxidative stress 
associated with aging. We demonstrated that the neuroprotective effects of 
EGCG and L-Carnosine are achieved through the modulation of HO-1/Hsp72 
systems. Our results indicate that the combined administration of EGCG and 
L-Carnosine  reduces the neuronal damage caused by oxidative stress. Since 
chronic oxidative stress plays a central role in the pathogenesis of many 
diseases, including HIV-1 associated disorders, the last part of the project 
aimed to investigate the age-related patterns of Nrf2 and HO-1 in different 
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brain regions and tissues of HIV-1 transgenic rat. The Nrf2/HO-1 axis 
constitutes a crucial cell survival mechanism to counteract oxidative stress 
and several recent studies have shown that bioactive food compounds can 
modulate Nrf2/HO-1 pathway. However, in the context of HIV-1 infection its 
role remains largely uncharacterized. In HIV-1 transgenic rat, we observed a 
significant reduction in the protein levels of Nrf2 and HO-1, suggesting a 
weakening in the cytoprotection exerted by Nrf2/HO-1 system. Moreover, the 
declined protein function of Nrf2 and HO-1 was accompanied by the 
acquisition of premature senescence phenotype in HIV-1 transgenic rat. 
Dietary inducers of Nrf2 and HO-1 may provide a novel strategy for restoring 
this pathway and mitigate oxidative stress during HIV-1 infection. 
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1. INTRODUCTION 
1.1 Food synergy: approaching a new generation   of 
 nutraceuticals  
The literal meaning of synergy is ‘working together’ but a useful definition is 
‘an effect seen by a combination of substances that is greater than would have 
been expected from a consideration of individual contributions’ (Heinrich, 
2004). In addition, combining the words “nutrition” and “pharmaceutical,” the 
word “nutraceuticals” refers to foods or food products that clinical evidence 
suggests may provide health and medical benefits, including for prevention 
and treatment of disease. Such products may be categorized as dietary 
supplements, specific diets, herbal products, or processed foods such as 
cereals, soups, and beverages. Dietary supplements can be extracts or 
concentrates and are found in many forms, including tablets, capsules, liquids, 
and powders. Vitamins, minerals, herbs, or isolated bioactive compounds are 
only a few examples of dietary ingredients in the products. Functional foods 
are designed as enriched foods close to their natural state, providing an 
alternative to dietary supplements manufactured in liquid or capsule form. 
Examples of nutritional and pharmacological synergies are increasingly 
widespread in the scientific literature (Jia, 2009; Ma, 2009; Ulrich-Merzenich, 
2009), and it should be noted that many single-target drugs cannot fully 
correct a complex disease condition or a pathological process (Keith, 2005). 
Isolated nutrients have been extensively studied in well-designed, long-term, 
large randomised clinical trials, typically with null and sometimes with 
harmful effects. For this reason, synergy assessment has become a key area in 
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nutritional studies. In particular, dietary phytochemicals such as quercetin, 
genistein, curcumin and catechins tend to increase the therapeutic effect by 
modulating one or more targets of the signal transduction pathway, by 
increasing the bioavailability of the other drug or, by stabilizing the other drug 
in the system (HemaIswarya, 2006). Flavonoids derived from almond skin 
acted synergistically with vitamins C and E to enhance resistance of human 
and hamster LDL cholesterol to oxidation (Chen, 2005). However, it is often 
argued that the bioavailability of dietary phytochemicals in target tissues is to 
low but there are numerous studies showing that by combining compound 
mixtures the bioavailability of certain bioactive food products can be 
improved. For example, piperin, the major alkaloid found in black pepper has 
been shown to improve the oral bioavailability of otherwise poorly absorbable 
compounds. One example is the combination of piperin and curcumin, leading 
to an improved bioavailability of curcumin, an anti-inflammatory and anti-
cancer phytochemical from turmeric (Gertsch, 2011). A recent work showed 
that pomegranate juice polyphenols, peel polyphenols, and oil exhibit synergy 
in inhibition of cancer cell proliferation (Lansky, 2005). Clearly, more work is 
needed to provide novel insights into the mechanisms by which specific food 
components work synergistically but may enhance the understanding of diet 
and health. 
 
1.2 Mitochondrial function, aging and  bioactive food 
 components 
Mitochondria play a central role in the cell metabolism and mitochondrial 
dysfunction has been recognized as an important contributor to an array of 
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human pathologies. Mitochondrial dysfunction is particularly associated with 
the onset and progression of many age-related disorders such as 
neurodegenerative and cardiovascular diseases as well as metabolic disorders 
and age-related muscle wasting (Harman, 1972; Trifunovic, 2008; Lanza, 
2010). The major components of the mammalian system of oxidative 
phosphorylation (OXPHOS) are the four complexes of the respiratory chain, 
and since OXPHOS complexes I-IV transfer electrons and consume most of 
the cellular oxygen, it is assumed that OXPHOS is the main cellular producer 
of reactive oxygen species (ROS) (Orrenius, 2007). The rate of the oxidant 
generation by mitochondria is a critical factor in aging, and the rate of 
peroxide generation increases with age (Richter, 1988). Moreover, 
mitochondrial biogenesis includes the cellular processes involved in the 
synthesis and degradation of the organelle and mitochondrial renewal is 
impaired in aging causing accumulation of damage to mitochondria (Gomez-
Cabrera, 2012). Several regulatory factors are implicated in the modulation of 
mitochondrial biogenesis and peroxisome proliferator-activated receptor- γ 
(PPAR- γ) coactivator 1 α (PGC-1 α) has emerged as a master regulator for 
the mitochondrial transcription and translation machinery (Scarpulla, 2008). 
In addition, PGC1-α appears to act as a central coordinator of multiple 
transcription factors (Wu, 1999). In particular, it has been shown that PGC1-α 
is able to strongly interact and co-activate the nuclear respiratory factor 1 
(NRF-1) (Puigserver, 2003). Furthermore, NRF-1 is implicated in the 
interaction with several mitochondrial genes including the mitochondrial 
transcription factor A (TFAM), one of the most important mammalian 
transcription factors for mitochondrial DNA (mtDNA) (Kaufman, 2007). 
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Noteworthy, recent evidence has highlighted NAD+-dependent protein 
deacetylase sirtuin 1 (SIRT1) as a critical factor for the regulation of 
mitochondrial function. Indeed, SIRT1 with PGC1-α and its regulatory circuit 
have been recognized to have a direct involvement in the control of 
mitochondrial biogenesis and metabolism (Aquilano, 2010). Therefore, 
PGC1-α constitutes an energy sensing cellular platform that controls 
mitochondrial function and its network provides a link between mitochondria 
and ageing that may be useful as an anti-ageing strategy. Several 
nutraceuticals have been found to attenuate the progression of age-related 
dysfunction (Prasain, 2010) and there are a variety of dietary strategies to 
ameliorate mitochondrial function in ageing (Ferrari, 2004). Flavonoids 
(apigenin, kaempferol, luteolin, myricetin, quercetin), grape/wine 
polyphenols, vitamin E, chlorophyllin (water-soluble chlorophyll analogue) 
and other phenols can protect membrane polyunsaturated fatty acids from 
oxidation, avoiding mitochondrial and other biomembrane disruptions 
(Ferrari, 2004). For instance, among isoflavones (members of the class of 
flavonoids) equol (the main active product of daidzein metabolism) has 
recently attracted scientific interest since its antioxidant activity may be useful 
in treating age-related diseases (Rüfer, 2006), however its influence on 
mitochondria is still poorly understood. On the contrary, resveratrol is a 
naturally occurring polyphenol with wide-ranging health benefits including 
well-established properties in promoting mitochondrial biogenesis during 
ageing (Ungvari, 2011). Therefore, studies to identify new nutritional 
interventions focused on improving mitochondrial function will be extremely 
beneficial to prevent mitochondrial decline. 
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1.3 Neuroprotective effects of L-carnosine and EGCG  
Aging is associated with disruption of cerebral function and increased 
susceptibility to neuronal loss. Nutrition has been recognized as an important 
factor in the modulation of disease and longevity and several studies suggest 
that consumption of diets rich in functional foods may help to counteract age-
related cognitive declines and the risk of developing neurodegenerative 
disease (Kapoor, 2009; Ferrari, 2004; Eussen, 2011; Perry, 2011). Moreover, 
oxidative stress has long been linked to the neuronal cell death and it is 
associated with certain neurodegenerative conditions (Andersen, 2004). (-)-
Epigallocatechin-3-gallate (EGCG) and L-Carnosine (β-alanyl-L-histidine, L-
Car) are among the very few nutraceuticals able to cross the blood brain 
barrier (Lin, 2007; Tanida, 2005). L-Car is an endogenous dipeptide found at 
high concentrations in glial and neuronal cells throughout the brain (Quin, 
1992). L-Car has been studied extensively and even though its functional role 
is still not completely understood many biological functions and therapeutic 
actions have been proposed. Several studies indicate that L-Car has useful 
features and significant neuroprotective actions by acting as anti-oxidant and 
free-radical scavenger (Kohen, 1988; Preston, 1998). For instance, nitrosative 
stress induced in astrocytes by LPS and INF-γ clearly increases the expression 
of inducible nitric oxide (iNOS) but the addition of L-Car markedly reduced 
iNOS expression, confirming a protective effect of the dipeptide (Calabrese, 
2005). In addition to its ability to quench an excess of ROS, L-Car has also 
been proposed as a metal chelating agent with beneficial effects in the context 
of neurodegenerative diseases (Trombley, 1998; Baran, 2000; Hipkiss, 2007). 
L-Car was suggested to be useful for preventing accumulation of aging 
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features by interfering with the glycation processes and preventing the 
crosslinking of glycoxidised proteins to physiological macromolecules 
(Rashid, 2007; Brownson, 2000). Noteworthy, many studies have shown the 
protective effect of L-Car in rescuing cells from amyloid-β (Aβ) neurotoxicity 
(Bellia, 2011). EGCG also has been reported to have antioxidant, anti-
glycating, metal-chelating, and neuroprotective activities (Jeong, 2004; Lee, 
2007; Weinreb, 2009; Davinelli, 2012). EGCG is a member of the catechin 
family and it is a major polyphenolic constituent of green tea leaves (Levites, 
2003). There are numerous epidemiological studies that have emphasized the 
health-promoting effects of EGCG and recently this compound has attracted 
scientific attention as a potential nutritional strategy to counteract age related 
chronic disorders and to improve longevity (Khan, 2007). In particular, 
reports demonstrated that EGCG was found to elevate the activity of two 
major antioxidant enzymes, superoxide dismutase (SOD) and catalase in mice 
striatum. Furthermore, it has been reported that EGCG is able to inhibit the 
nuclear translocation of nuclear factor-kappa β (NF-kβ) in human 
neuroblastoma SH-SY5Y cells (Weinreb, 2009). Dietary antioxidants, such as 
L-Car and EGCG have recently demonstrated to be neuroprotective through 
the modulation of proteins such as heat shock protein 70 (Hsp70) and heme 
oxygenase-1 (HO-1) (Calabrese, 2011; Bellia, 2005). Hsp72 is the major 
stress inducible form of cytosolic Hsp70 and one of the best studied 
chaperones of the Hsp70 family which consists of at least 12 members 
(Tavaria, 1996). Hsp72 confers a cytoprotective role against various 
environmental stresses (Velazquez, 1984) and several neuroprotective effects 
have been shown against a variety of insults (Brown, 2007). A wide array of 
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exogenous factors and physiological signals are able to induce transcription 
and translation of Hsp72, including inflammatory response and oxidative 
stress (Dybdahl, 2005; Calabrese, 2001). During stressor exposure different 
intracellular signals are involved in the expression/release of Hsp72 which is 
coupled to activation of signalling pathways such as Toll-like receptors, 
adrenoreceptors, and NF-kB (Ortega, 2012) inducing a plethora of adaptive 
responses. HO-1 is one of the phase II enzymes and it is involved in the 
metabolism of heme for iron reutilization and oxidative stress tolerance (Poss, 
1997). Specifically, this stress-inducible intracellular enzyme plays a pivotal 
role in the degradation of heme into carbon monoxide (CO), ferrous iron, 
biliverdin, and bilirubin (Chung, 2008). The cytoprotective effect of HO-1 
may be attributed to its by-products, i.e. bilirubin, CO and free iron (Ryter, 
2006). Moreover, the products of heme degradation have strong influence on 
inflammatory processes and the induction of HO-1 pathway has been shown 
to act as a powerful defensive mechanism for tissues exposed to an oxidant 
challenge. Therefore, the induction of Hsp72 and HO-1 by bioactive food 
components may be crucial to reduce or prevent the neuronal damage.  
 
1.4 Relevance of Nrf2/HO-1 axis during the oxidative 
 imbalance in HIV-1 infection 
Substantial advances have been made over the past three decades to elucidate 
the complex pathobiological events related to the acquired immune deficiency 
syndrome (AIDS) caused by human immunodeficiency virus-1 (HIV-1). 
Multiple studies have shown that constitutive production of inflammatory 
mediators and radical species may significantly contribute to the severity and 
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progression of AIDS (Turchan-Cholewo, 2009; Deeks, 2011; Le Saux, 2012). 
Deregulation of inflammatory processes is a hallmark of HIV-1 infection 
(Appay, 2008) which may further increase the sustained cellular redox 
imbalance observed in HIV-1 infected patients (Gil, 2003). Indeed, several 
authors have recently claimed the crucial role of oxidative stress in the 
pathogenesis of HIV-1-related diseases (Lassiter, 2009; Husain, 2009). In 
particular, it was reported that HIV-1 proteins such as envelope glycoprotein 
gp120 (gp120) and transactivator of transcription (Tat) cause oxidative stress 
and cellular dysfunction in tissues and cells that are not generally infected by 
the virus (Price, 2005; Fan, 2013). It has also been proven that viral proteins 
released extracellularly may interact with uninfected cells and play a critical 
role to promote inflammation or affect the intracellular redox balance (Nath, 
2002). Therefore, chronic inflammation and persistent alterations of redox 
signaling during HIV-1 infection contribute to the premature occurrence of 
age-related comorbidities, including liver disease and neurocognitive 
impairment (Bathia, 2012). The rise of HIV-1-associated non-AIDS 
conditions attributed to highly active antiretroviral therapy (HAART) and 
commonly observed in the elderly suggests a new and fascinating paradigm 
describing HIV-1 infection as amodel of accelerated aging (Pathai, 2013). 
Although the premature aging of the immune system of HIV-1 carriers has 
been demonstrated (Desai, 2010), convincing evidence to support the role of 
oxidative stress theory of aging in HIV-1 are still lacking. Although consistent 
oxidative imbalance affects the body during HIV-1 infection (Ngondi, 2006; 
Mandas, 2009 ), very limited experimental data are available. The 
deregulation of redox-sensitive stress response may be due to multiple factors 
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such as exposure to circulating "virotoxins" in the extracellular environment 
(Nath, 2002), presence of oxidized proteins in several brain regions, including 
prefrontal cortex and hippocampus (Mollace, 2001; Mattson, 2005), or the 
virus making the liver more vulnerable to oxidative stress (Lin, 2013). 
Recently, the essential role of nuclear factor erythroid 2-related factor 2 
(Nrf2) in the context of HIV-1 infection has obtained growing attention and 
interest (Deramaudt, 2013). Nrf2 acts as a sensor of oxidative and 
electrophilic stress and serves as a master switch in the networks coordinating 
the induction of a battery of protective genes that are crucial for 
cytoprotection and cell survival (Niture, 2013). In addition, HO-1 plays a 
pivotal role in the maintenance of cellular redox homeostasis (Scapagnini, 
2004) and its expression is mainly regulated by Nrf2. These two systems are 
essential components of the cellular stress response and they display 
combined critical biological activities to efficiently counteract oxidative stress 
and inflammation (Paine, 2010). Noteworthy, HO-1 activity is a potent 
defense factor for HIV-1 infection and a direct correlation between HO-1 
induction and inhibition of HIV-1 replication has been shown (Devadas, 
2006). Several recent studies have shown that nutritional compounds can 
modulate the activation of Nrf2/HO-1 axis (Scapagnini, 2011) and these 
compounds may have a positive impact on this pathway during HIV-1 
infection. A recent study showed that EGCG supplementation significantly 
improved the changes associated with Tat-induced oxidative stress. The HIV-
1 Tat activates the NF-kB signaling transduction pathway, which is necessary 
for viral replication. By increasing the nuclear levels of Nrf2, EGCG 
decreased the levels of NF-kB and ROS production in cells transfected with a 
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Tat plasmid. These data suggest that the Nrf2 signaling pathway is the 
primary target for the prevention of increased viral gene expression Tat-
induced HIV-1 by EGCG which reduces NF-kB (Zhang, 2012). Thus, these 
studies suggest that bioactive food compounds have the ability to activate the 
Nrf2 pathway, increases the activity of antioxidant enzymes such as HO-1 and 
may be useful to modulate Nrf2/HO-1 system during HIV-1 infection.  
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2. AIM OF THE STUDY  
Emerging evidence suggests that combinatorial action of numerous 
biologically active compounds may be a valuable source in a variety of 
therapeutic applications. Moreover, the benefits of multi-target action are well 
established in a variety of pathological models. Therefore, identification of  
novel synergisms may provide a new perspective for future treatments aiming 
to modulate crucial biological pathways involved in the pathomechanism(s) of 
many disorders. Many dietary supplements and nutraceuticals may be useful 
to augment the efficacy of pharmacological approaches or provide 
physiological benefit to improve age-related decline. Aging process is 
characterized by a general decline in cellular activity and it is also associated 
with a decrease in mitochondrial function correlated to the onset and 
progression of age-related pathologies. In this context, it should be noted that 
oxidative stress play a central role in age-related cognitive declines and in the 
risk of developing neurodegenerative disease. Persistent alterations of redox 
signaling contributes to many of the abnormalities associated with the 
pathogenesis of many diseases, including HIV-1 related disorders. In addition, 
the partial successful of HAART caused an increase in the life expectancy of 
HIV-1 infected patients leading to frailty syndrome and age-related diseases 
during HIV-1 infection. The Nrf2/HO-1 axis constitutes a crucial cell survival 
mechanism to counteract oxidative stress and its role in HIV-1 remains largely 
uncharacterized. For all these reasons, we first examined whether the 
combination of two polyphenols (resveratrol and equol) would be more 
effective to modulate mitochondrial function. We next investigated the 
combined effect of two known nutraceuticals such as L-Car and EGCG on the 
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activation of two stress-responsive pathways to achieve cytoprotection against 
oxidative stress-induced cell damage.Finally, in order to design future 
treatments during the redox imbalance caused by HIV-1 infection, we further 
characterized the Nrf2/HO-1 system, which is the main pathway associated 
with the oxidative stress response and mainly modulated by dietary 
compounds. 
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3. EXPERIMENTAL PROCEDURES 
3.1 Materials 
3.1.1 HUVEC cell culture 
HUVEC were obtained from Lonza and maintained in endothelial basal 
medium (EBM-2) supplemented with growth factors (Lonza). Cells were 
grown at 37°C in 5% CO2 and serial passages were performed when the cells 
reached a 80% confluence. As described by Grillari et al. (Grillari, 2000) at 
around 30 passages when the cells exhibited the irreversible growth arrest, 
they were used for the experimental procedures. HUVEC cells were treated 
with resveratrol (trans-3, 4, 5,-trihydroxystilbene) (purity 98%) purchased 
from Cayman Chemical Company and equol ((3S)-3-(4-Hydroxyphenyl)-7-
chromanol) (purity 98%) purchased from INDOFINE Chemical Company.  
 
3.1.2 Neuronal culture 
The embryos were extracted from a 17-day pregnant Wistar rat (Harlan-
Sprague-Dawley). The fetuses were sacrificed and the heads placed in high 
glucose phosphate buffered saline (PBS) (Sigma). The brains were then 
quickly dissected under a stereomicroscope to isolate brain cortex, which was 
then cut into small fragments and exposed to papain, activated in the presence 
of cysteine and ethylen-diaminotethracetic acid (EDTA), for 9 minutes at 
37°C. The fragments were mechanically dissociated through a fire-polished 
Pasteur pipette to obtain single cells suspension. The cell suspension was 
layered onto a gradient consisting of 2 ml Earle's balanced salt solution 
(Gibco) containing 20 mg of bovine serum albumin and 20 mg of trypsin 
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inhibitor (ovomucoid), and then centrifuged. The pellet was successively 
resuspended in high-glucose Dulbecco's modification of Earle's medium 
containing 10% heatinactivated fetal bovine serum (Gibco,) and antibiotics 
(100 IU/ml of penicillin and 100 μg/ml of streptomycin) (ICN-Biomedicals). 
The cells were then counted and tested for viability using the trypan blue 
exclusion test (viability was > 99%). Finally, the cells were seeded onto 25 
cm
2
 T-flasks (Corning) previously coated with poly-D-lysine. After 48 hours, 
1 μM cytosine arabinoside was added to the cells to inhibit glial cell growth. 
Cell cultures were incubated at 37°C in a humid 5% CO2  and 95% air 
environment. This protocol produced an enriched neuronal culture. For the 
cell treatment we used the following compounds: 3,4,5-Trihydroxybenzoic 
acid (2R,3R)-3,4- dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-
benzopyran- 3-yl ester, (TEAVIGO
TM
, purity min. 94 %) and L-Car (Sigma, 
purity min. 98 %). 
 
3.1.3 Animals 
The HIV-1 transgene (NL4-3Δgag/pol) construction and generation of the 
HIV-1 TG have been previously described in detail (Reid, 2001). Age-
matched male HIV-1 TG rats and genetic background control Fisher 344 
(F344) were used and experiments were designed to study the following age 
groups: young (3-months-old), adult (12-months-old), and aged (23-months-
old). The animals were housed under pathogen free conditions and food and 
water were provided ad libitum. Rats were anaesthetized with an overdose of 
CO2 and sacrificed. Spleen and liver were quickly removed, washed with cold 
PBS and immediately frozen at -80 °C until use. Whole brain was rapidly 
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excised and the hemispheres were either directly snap-frozen or further 
dissected on ice to prepare the following brain regions: hippocampus, cortex 
and cerebellum. The left and right sides of the brain were randomly chosen for 
either protein or gene expression analyses and kept at -80 °C until processed. 
 
3.2 Methods 
3.2.1 MitoTracker® Red staining 
The HUVEC cells were subdivided into three groups, which were treated, as 
previously tested (Csiszar, 2009) with resveratrol, 10 μM for 48 hours, equol 
10 μM (Kamiyama, 2009) for 48 hours, and with the composition containing 
resveratrol and equol 10 μM for 48 hours, respectively. The mitochondrial 
mass in HUVEC was determined selectively loading mitochondria with 
Mitotracker fluorescent red dye (Invitrogen). Fluorescent calcein (green) and 
Hoechst 33258 (blue) dyes were used to stain the cytoplasm and the nuclei, 
respectively. The mitochondrial density-area was calculated with respect to 
cytoplasmatic volume using Zeiss AxioVision imaging software (Zeiss). Only 
cells with intact cytoplasmatic calcein stain were included in the analysis. 
 
3.2.2 Histochemical staining for senescence associated β-
galactosidase (SA-β-gal) 
SA-β-gal activity was detected by a histochemical procedure, as previously 
described (Debacq-Chainiaux, 2009). Briefly, the tissues and the brain were 
frozen and embedded in tissue freezing medium (TBS, Fisher Scientific). 
Sections were cut on a cryostat and mounted onto Superfrost/Plus microscope 
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slides (Fisher Scientific). Sections were fixed in 1% formaldehyde for 1 min, 
washed in PBS, and stored at -80 °C until used for SA-β-gal staining. Slides 
were immersed in X-Gal staining solution (pH 6) and after overnight 
incubation in the dark at 37 °C, sections were washed in PBS and viewed 
under bright field. SA-β-gal activity was determined by the detection of 
stained blue-green tissues. 
 
3.2.3 Tat and gp120 immunohistochemistry 
Tissues from TG and Fisher 344 Sprague–Dawley control rats were fixed in 
10% neutral buffered formalin and embedded in paraffin. Five-microgram 
tissue sections (spleen and lymph nodes) were used and a modified 
avidin/biotin method was used for immunohistochemical localization of HIV 
gene products (Wiley, 1986). Paraffin sections were processed and treated 
with avidin/biotin blocking solution (Vector Laboratories) and non-immune 
sera appropriate for blocking the secondary antibody at a 1:5 dilution. Primary 
antibodies included mouse anti-HIV-1 gp120 monoclonal antibody (NEN), 
diluted 1:150; mouse anti-HIV-1 Tat monoclonal antibody (NEN), diluted 
1:100. Biotinylated secondary antibodies were incubated for 2 h at room 
temperature with anti-mouse IgG (rat-absorbed) (Vector Laboratories), at 
dilutions of 1:200, and labeled with Vecta Stain Elite ABC kit (Vector 
Laboratories), followed by addition of 3,3′-diaminobenzidine 
tetrahydrochloride (DAB) peroxidase (Sigma).  
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3.2.4 Nitrotyrosine detection by immunohistochemistry 
The brain was rapidly removed intact and frozen at −80°C. Nitrotyrosine was 
detected immunohistochemically in brain sections as an indicator of the 
presence of peroxynitrite and other nitrosating agents, as previously described 
(Scott, 1999). Sections were incubated overnight with 1:500 dilution of 
primary anti-nitrotyrosine antibody (Upstate Biotechnology), and specific 
labeling was detected with avidin-biotin peroxidase complex (Vectastain Elite 
ABC kit, Vector Laboratories.). 
 
3.2.5 SIRT1 activity assay 
Nuclear SIRT1 activity was evaluated in cells treated with resveratrol, equol 
and resveratrol + equol as described previously by Ferrara et al. (Ferrara, 
2008). We measured SIRT1 using a deacetylase fluorometric assay kit (Sir2 
Assay Kit, CycLex, Ina). The final reaction mixture (100 μL) contained 50 
mM Tris–HCl (pH 8.8), 4 mM MgCl2, 0.5 mM DTT, 0.25 mA/mL Lysyl 
endopeptidase, 1 μM Trichostatin A, 200 μM NAD, and 5 μL of extract 
nuclear sample. All determinations were performed in triplicate. 
 
3.2.6 Heme Oxygenase Activity Assay 
Microsomes from harvested cells were added to a reaction mixture containing 
NADPH, glucose-6-phosphate dehydrogenase, rat liver cytosol as a source of 
biliverdin reductase, and the substrate hemin. The mixture was incubated in 
the dark at 37°C for 1 hour and the reaction was stopped by the addition of 1 
ml of chloroform. After vigorous vortex and centrifugation, the extracted 
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bilirubin in the chloroform layer was measured by the difference in 
absorbance between 464 and 530 nm (e= 40 mM-1cm-1). 
 
3.2.7 Cell Viability  
Cell viability was determined in cortical neurons treated for 12 hours with 
EGCG 25 μM, L-Car 25 μM, or with EGCG 25 μM + LCar 25 μM, followed 
by incubation for 2 hours in the presence of glucose oxidase (50 mU/ml). 
After treatment with glucose oxidase, cells were washed and exposed to 
complete medium containing 1% Alamar blue for 5 hours according to 
manufacturer’s instruction (Serotec). After the incubation period, optical 
density in the medium of each well was measured using a plate reader 
(Molecular Devices). The intensity of the red color is proportional to the 
viability of cells, which is calculated as difference in absorbance between 570 
nm and 600 nm and expressed as percentage of untreated cells. 
 
3.2.8 Quantitative real-time PCR for mitochondrial DNA 
Total DNA was extracted from HUVEC cells using the DirectPCR lysis 
reagent (Viagen Biotech). The number of mtDNA copies was quantified by 
qRT-PCR according to the protocols of Adabbo et al. (Adabbo, 2009). Two 
different housekeeping genes were used (cytochrome oxidase III and β-actin) 
for normalization. mtDNA per nuclear genome was calculated as the ratio of 
cytochrome oxidase III (mitochondrial) DNA to β-actin (nuclear) DNA. 
Quantification was performed using the ΔΔCT method. 
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3.2.9 Measuring the mRNA expression of mitochondrial 
biogenesis factors via quantitative real-time PCR 
The qRT-PCR technique was used to determine the effect of resveratrol, equol 
and of the mixture of the two compounds (resveratrol + equol) (10 μM for 24 
h) on mRNA expression of mitochondrial biogenesis factors such as Nrf-1, 
TFAM and PGC1-α in HUVEC cells using Light Cycler technology (Roche 
Molecular Biochemicals). The total RNA was isolated with Mini RNA 
isolation II Kit (Zymo Research) and was reverse transcribed using 
SuperScript III RNase H-free reverse transcriptase (Invitrogen). Efficiency of 
the PCR reaction was determined performing dilution series of a standard 
sample. Hypoxanthine phosphoribosyltransferase (HPRT) was used for 
internal normalization and quantification was performed using ΔΔCT method. 
 
3.2.10 Real Time Quantitative RT-PCR to measure HO-1 and 
Hsp72 gene expression  
Total RNA from cell cultures was extracted using Trizol (Sigma, St. Louis, 
MI, USA). Single stranded cDNAs were synthesized incubating total RNA (1 
μg) with SuperScript II RNase H reverse transcriptase (200 U), oligo-(dT) 
primer (100 nM), dNTPs (1 mM), and RNase-inhibitor (40 U) at 42 °C for 1 
hour in a final volume of 20 μl. Reaction was terminated by incubating at 70 
°C for 10 min. Forward (FP) and reverse (RP) primers were used to amplify 
HO isoforms. The expected amplification products for HO-1, HO-2 are 123 
and 331 base pairs, respectively. Aliquots of cDNA (0.1 and 0.2 μg) and 
known amounts of external standard (purified PCR product, 102 to 108 
copies) were amplified in parallel reactions. Each PCR reaction (final volume 
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20 μl) contained 0.5 μM of primers, 2.5 mM Mg2+ and 1 x Light cycler DNA 
master SYBR Green (Roche Diagnostics). PCR amplifications were 
performed with a Light-Cycler (Roche Molecular Biochemicals). 
Quantification was performed by comparing the fluorescence of PCR products 
of unknown concentration with the fluorescence of the external standards. For 
this analysis, fluorescence values measured in the log linear phase of 
amplification were considered using the second derivative maximum method 
of the Light Cycler Data Analysis software (Roche Molecular Biochemicals). 
Specificity of PCR products obtained was characterized by melting curve 
analysis followed by gel electrophoresis, visualized by ethidium bromide 
staining. 
 
3.2.11 RNA isolation and quantitative real-time RT–PCR in 
different tissues of HIV-1 TG rat 
Total RNA was extracted from spleen, liver, whole brain, hippocampus, 
cortex and cerebellum homogenates, using TRIzol (Invitrogen) and QIAamp 
Rneasy Mini Kit (Qiagen), and DNase I-digested (Invitrogen). Quantity and 
quality of RNA were determined using a NanoDrop spectrophotometer 
(Thermo Scientific). cDNA was synthesized using iScript™ cDNA Synthesis 
Kit (Bio-Rad). Aliquots of cDNA were used to perform a quantitative real-
time RT-PCR using iQ™ SYBR® Green Supermix Kit (Bio-Rad) with an 
iQ™5 Multicolor Real-Time PCR Detection System (Bio-Rad). Primers 
(Nrf2, HO-1, Tat, GADPH, and β-actin) were designed for each gene using 
NCBI/primer-blast program and were synthesized by Sigma-Aldrich. 
Specificity of PCR products obtained was characterized by melting curve 
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analysis followed by gel electrophoresis. The fold-change in gene expression 
was quantified by the ΔΔCT method and the data are expressed as the relative 
level of the target gene in the HIV-1 TG rat normalized to the internal control 
(β-actin) and compared with F344 wild-type counterpart. All reactions were 
carried out in triplicate. 
 
3.2.12 Western Blot Analysis for HO-1 
After treatment with ECGC and/or L-Car, samples of neurons were analysed 
for HO- 1 protein expression using a western immunoblot technique. An equal 
amount of proteins (30 μg) for each sample was separated by SDS-
polyacrylamide gel electrophoresis and transferred to nitrocellulose 
membranes. Proteins were estimated by using bicinchoninic acid reagent. The 
nonspecific binding of antibodies was blocked with 3% nonfat dried milk in 
Tris buffered saline (TBS-T). Membranes were then probed with a polyclonal 
rabbit anti-HO-1 antibody (Stressgen Victoria, BC) (1:1000 dilution in TBS-
T, pH 7.4), for 2 hours at room temperature. After three washes with TBS-T, 
blots were visualized using an amplified alkaline phosphatase kit from Sigma 
(Extra-3A), and the relative density of bands was analyzed by the use of an 
imaging densitometer (model GS-700; Bio-Rad). 
 
3.2.13 Western blot in HIV-1 TG rat  
The spleen, liver, whole brain, hippocampus, cortex and cerebellum were 
homogenized in RIPA lysis buffer in the presence of a protease inhibitor 
cocktail (Sigma-Aldrich). Extracts were subjected to centrifugation at 10,000 
rpm for 20 min. Protein concentration was determined using the Bradford 
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protein assay. Equal amounts of protein extract were electrophoresed (12% 
SDS-polyacrylamide) and electrotransferred onto PVDF membrane (Bio-
Rad). Membranes were blocked with 5% non-fat milk dissolved in PBS 
containing 0.1% Tween-20 (PBST) for 1 h. The membranes were incubated 
overnight at 4°C with primary antibodies and the immunoblots were 
performed by using the following antibodies: anti-rat Nrf2 (rabbit polyclonal, 
1:1000 diluition, Abcam), anti-rat HO-1 (rabbit polyclonal, 1:1000 diluition, 
Abcam), anti-rat β-actin (rabbit polyclonal, 1:1000 diluition, Cell Signalling). 
Membranes were washed with PBST incubated with respective HRP 
conjugated secondary antibodies (Santa Cruz, Inc.). After further washing in 
PBST, the membranes were detected using an ECL chemiluminescent 
substrate kit (Invitrogen) and exposed to Kodak X-ray film. The bands were 
quantified by ImageJ software, and normalised to β-actin, which served as an 
internal control. 
 
3.2.14 Statistical analysis 
In cells treated with EGCG and L-Car, differences were analyzed by using 
one-way analysis of variance combined with the Bonferroni test. Values were 
expressed as the mean ± S.E.M., and differences between groups were 
considered to be significant at p < 0.05. In cells treated with resveratrol and 
equol, differences between various treatments were analysed by unpaired 
Student’s t-tests with P values <0.01 considered highly significant and P < 
0.05 considered significant. In the experiments involving HIV-1 TG rat, the 
values presented in the graphs are the means for at least three experiments. 
Results are expressed as mean ± standard error of the mean (SEM) of three or 
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more experiments. Student’s “t” test was used to assess differences between 
groups; a P value of <0.05 was considered significant. 
 
4. RESULTS 
4.1 Enhancement of mitochondrial biogenesis by   
 resveratrol and equol 
4.1.1 Combination of resveratrol and equol induces  
mitochondrial biogenesis in HUVEC 
We examined the combined treatment of resveratrol and equol on HUVEC 
cells to identify their effects on the mitochondrial biogenesis. In particular, the 
primary goal of this investigation was to determine whether combining 
resveratrol and equol would increase the expression of key factors involved in 
mitochondrial biogenesis. The Mitotracker staining showed that mitochondria 
were located in the perinuclear region in HUVEC (data not shown). Treatment 
with resveratrol increased significantly the density-area ratio in Mitotracker-
labeled endothelial cells as compared to the cytoplasmatic volume (Fig. 7A). 
The enhanced mitochondrial biogenesis in cells treated with both compounds 
simultaneously was also confirmed by the increased cellular mtDNA content 
(Fig. 7B). Overall, we found that co-treatment with resveratrol and equol 
positively affect mitochondrial biogenesis. 
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Figure 7: The combined treatment of resveratrol and equol strongly increased the 
number of mitochondria in HUVEC cells. (A) Mitotracker fluorescent intensities 
were analysed to assess the mitochondrial biogenesis. (B) Relative mitochondrial 
DNA (mtDNA) content was estimated by qRT-PCR. Representative data of at least 
3 experiments each performed in triplicate. (*= P < 0.05, **= P < 0.01). C: control; 
E: equol; R: resveratrol; E+R: equol + resveratrol. 
 
4.1.2 Induction of SIRT1 by the association of resveratrol and 
equol 
Analysis of the effect of a combined administration of resveratrol and equol 
showed an increase in SIRT1 enzymatic activity in HUVEC endothelial cells 
(Figure 8). Although equol was much less effective to induce SIRT1, the 
effect of a combination of resveratrol and equol was greater than the response 
achieved by the single compounds (Figure 8). 
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Figure 8: Increase of SIRT1 enzymatic activity by combined administration of resveratrol and 
equol. Fluorimetric SIRT1 activity assay to determine the effect achieved in HUVEC by the 
combined exposure to equol and resveratrol. Representative data of at least 3 experiments 
each performed in triplicate. (*= P < 0.05, **= P < 0.01). AFU: arbitrary fluorescence units; 
C: control; E: equol; R: resveratrol; E+R: equol + resveratrol. 
 
4.1.3 The association of resveratrol and equol activates 
 mitochondrial biogenesis factor 
PGC1-α is involved in regulating the expression of mtDNA via increased 
expression of TFAM which is co-activated by NRF-1 (Handschin, 2009). We 
used qRT-PCR measurements to analyse the expression of PGC1-α, NRF-1 
and TFAM. The results indicate that these mitochondrial biogenesis factors 
were strongly increased by combined treatment of resveratrol and equol (Fig. 
9). 
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Figure 9: Effect of resveratrol and equol on mRNA expression of PGC1-α (A), NRF-1 
(B), TFAM (C) in HUVEC. qRT-PCR measurement to assess the mRNA 
expression of the mitochondrial biogenesis factors. Representative data of at least 3 
experiments each performed in triplicate. (*= P < 0.05, **= P < 0.01). C: control; 
E: equol; R: resveratrol; E+R: equol + resveratrol. 
 
4.2. Synergistic Effect of L-Carnosine and EGCG in 
modulating HO-1 and Hsp72 
4.2.1 Synergistic effect of EGCG/L-Car supplementation in 
preventing neuronal cell death 
To assess the neuroprotective activity of EGCG, L-Car and of a mixture of the 
two compounds, cell viability was determined in mouse cortical neurons 
treated with different doses (0-100 μM) of the two compounds for 12 hours 
(Fig. 1). A significant decrease of viability of about 25% was observed only at 
the 100 μM dose of EGCG. We therefore decided to use the combination of 
the two compounds (25 μM each) before exposing the cells for 2 hours to 
glucose oxidase (50 mU/ml).  
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Figure 1: Cell viability of mouse cortical neurons. The cells were treated for 12 hours with 
15, 25, 50 and 100 μM of EGCG or L-Car *P<0.01.  
The glucose oxidase generates hydrogen peroxide at a constant rate and it is 
known to produce cellular injury in vitro (Chang, 1996). Treatment of cells 
for 2 hours with glucose oxidase resulted in 27% of residual cell viability 
(Fig. 2). Exposure of cells for 12 hours to 25 μM EGCG reduced glucose 
oxidase mediated damage, rising cell viability to 51% (24% more than the 
glucose oxidase treatment alone). L-Car at 25 μM concentration was less 
effective in protecting cells from oxidative damage, giving a viability of 33% 
(7% more than the glucose oxidase treatment). Remarkably, the association of 
the two compounds protected cells in a synergistic way, giving a rate of 
neuronal survival of 76% (49% more than the glucose oxidase treatment, 
which is more than the expected additive effect of 31%). 
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Figura 2: Cell viability of mouse cortical neurons exposed to glucose oxidase. The cells 
were treated for 2 hours with 50 mU/ml of glucose oxidase after exposure for 12 
hours with 25 μM of EGCG, L-Car or EGCG + L-Car.* P<0.01; **P<0,001. 
 
4.2.2 Stimulation of the HO-1 and Hsp72 Pathways by 
EGCG/L-Car supplementation 
We assessed the ability of EGCG and L-Car to elicit the HO-1 and the Hsp72 
pathways by measuring HO-1 and Hsp72 gene expression through 
quantitative real-time PCR. HO-1 and Hsp72 
mRNA steady state levels were measured following administration of 
increasing doses of EGCG and L-Car (Fig. 3). 
 
Figura 3: Stimulation of HO-1 and Hsp72 mRNA levels. Mouse cortical neurons were 
treated with increasing doses of EGCG and L-Car (5, 15, 25, 50 or 100 μM) and 
the levels of HO-1 and Hsp72 mRNA were measured. *P<0.01. 
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Compared to the not-inducible HO-2 paralog gene, EGCG elicits a dose-
dependent increase of HO-1 mRNA, which reaches the maximum (about 8 
fold) at 25 μM, and decreases subsequently at 50 and 100 μM. LCar is instead 
much less active in inducing HO-1 gene expression at the same 
concentrations, and stimulates HO-1 maximum expression at 25 μM. An 
opposite behaviour is observed for Hsp72 gene expression which is 
normalized according to the levels of the paralog not inducible gene Hsc70. 
EGCG administration gives a dose dependent enhancement of Hsp72 
expression at the highest  concentration of 50 μM and 100 μM. The last 
concentration is also associated to a 25% decrease in cell viability (see Fig. 1). 
The 25 μM dose, known to have no effects on cell viability, does not enhance 
Hsp72 gene expression in a statistically significant way. L-Car at the same 
concentration induces an increase of Hsp72 of about 8- fold (Fig. 3). To 
confirm that the increase in HO-1 gene expression corresponded to an 
equivalent increase in HO-1 activity, we measured the amount of bilirubin, as 
indicator of HO-1 activity, after 6 and 24 hours of EGCG and L-Car 
treatments in presence of glucose oxidase. We observed an increase in HO-1 
activity that was comparable to the enhanced mRNA expression, confirming 
the functional significance of the data obtained by the real time PCR 
determinations (Fig. 4). 
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Figura 4: Heme oxygenase activity of mouse cortical neurons. The amount of bilirubin 
was measured after 6 and 24 hours on cells treated with 5, 15, 25, 50 or 100 μM of 
EGCG or L-Car. * P<0.01. 
 
4.2.3 L-Car contributes to an increase in the levels of HO-1 
To estimate the contribution of HO-1 in the synergistic neuroprotective effect 
of EGCG and L-Car we repeated the first experiment by adding also Tin 
protoporphirin IX (ZnPP), a compound known to potently and specifically 
inhibit HO-1 activity. As shown in Fig. 5, the inhibition of HO-1 activity 
caused by ZnPP reduced the neuroprotective effects of the combination of the 
two compounds by 35%, bringing it to the level obtained with EGCG alone. 
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Figura 5: Cell viability of mouse cortical neurons exposed to HO-1 inhibitor (ZnPP). The 
cells were exposed for 2 hours into 50 mU/ml glucose oxydase after treatment for 
12 hours with 25 μM of EGCG, L-Car, EGCG + L-Car or 10 μM ZnPP. *P<0.01; 
**P<0,001. 
 
Determination of HO-1 by western blotting after EGCG and L-Car 
administration showed that EGCG strongly increased HO-1 expression while 
L-Car was much less effective. Similar results were already showed by 
quantitative real-time PCR. Interestingly their combination enhanced HO-1 
protein levels in a synergistic way at 25 μM dose of treatment and decreased 
HO-1 expression at higher concentration (50 μM) of the compounds (Fig. 6). 
Therefore, a contribution of L-Car could be observed also in terms of 
cooperative increase in the levels of HO-1, which is primarily induced by 
EGCG. 
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Figura 6 Protein levels of HO-1 estimated by densitometry of bands of western blot. 
Neurons were treated with 25 μM of EGCG or L-Car and with, 25 or 50 μM of 
EGCG + L-Car. Levels of HO-1 are normalized to β-actin. * P<0.01. ** P<0.001. 
 
4.3 Altered expression pattern of Nrf2/HO-1 axis during 
accelerated-senescence in HIV-1 transgenic rat 
 
4.3.1 Detection of HIV-1 Transgene Expression 
We performed a RT-PCR followed by gel electrophoresis (Fig. 10) to 
demonstrate the expression of HIV-1 transcript that encodes Tat in the HIV-1 
TG rat. PCR was conducted to use a set of primers that only gives rise to PCR 
product if the HIV-1 transcript encoding for the Tat gene was expressed.  
 
Figure 10: Detection of HIV-1 Tat by RT-PCR in HIV-TG rat. Splenocytes were 
extracted from A) Fischer, F344 and  B) HIV-1 TG rat.Formalin-fixed paraffin-
embedded 5 sections of spleen from line 1 TG rats were analyzed by 
immunohistochemistry for Tat and gp120. All two proteins were evident in 
cells within the lymph-node tissues (Fig. 11). 
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Figure 11: Detection of HIV-1 gp120 and Tat protein in HIV-1 TG rats. HIV-1 Tat and 
      gp120 detected from lymph-node tissues by immunocytochemical analysis 
 
4.3.2 Increased nitrosative stress in the brain of HIV-1 TG rat 
Figure 12 shows the results of immunohistochemical detection of 
nitrotyrosine in representative brain sections from Fischer F344 and HIV-1 
TG rat . Nitrotyrosine, an indicator of peroxynitrite formation and other 
nitrosating agents, was detected in the brain HIV-1 TG rat, whereas no 
staining was observed in brain regions of F344. 
 
a) Fischer 344 rat b) HIV-1 Tg rat
 
Figure 12: Nitrotyrosine staining in brain of F344 and HIV-1 TG rats. Representative 
     photomicrograph of a brain section taken from a) wild-type F344 rat and b) HIV-1 
     TG rat. Intense positive staining of nitrosative species  was found in HIV-1 TG rat. 
     Scale bar: 100 μm. 
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4.3.3 Protein decline of Nrf2 and HO-1 in spleen and liver of HIV-TG rat 
As reported by Reid et al. (Reid, 2001) viral transcripts and proteins were 
identified in several tissues of HIV-1 TG rat, including spleen and liver. To 
gain insight into the role of Nrf2 in the pathogenesis of HIV-1, we 
investigated its protein content in spleen extract from 3, 12 and 23 months-old 
rats by western blot analysis. Nrf2 protein was undetectable in the spleen of 
both wild-type and HIV-1 TG 3 months-old animals. Consistently, Nrf2 
protein was significantly lower in the 12 and 23 months-old HIV-1 TG rats as 
compared tocontrol animals (Fig. 13a). In contrast, the Nrf2 RNA levels 
quantified by qRT-PCR did not exhibited any substantial changes in the 
spleen from 3, 12 and 23 months-old HIV-1 TG rats compared to F344 
animals (Fig. 13b), which excludes impairment in the transcriptional 
regulation of Nrf2. We next examined whether the pattern detected in Nrf2 
levels was accompanied by a corresponding trend in HO-1 expression. Similar 
to the above findings, HO-1 protein declines significantly in each age group of 
HIV-1 TG rat spleen as compared to non-transgenic controls (Fig. 13c). 
Unexpectedly, HO-1 RNA levels were still present in all three transgenic 
groups with a slight increase at 12 months (Fig. 13d). These results suggest 
that in the spleen of HIV-TG rat, the downregulation of Nrf2 and HO-1 may 
be controlled primarily at the post-transcriptional level. 
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Figure 13: Nrf2 and HO-1 expression in the spleen of HIV-1 TG and F344 rats of 
varying ages. Western blot and densitometric analysis of total Nrf2 (a) and HO-1 
(c)  from spleen homogenates of young group: 3 months old; middle-aged 
group: 12  months old; and aged group: 23 months old (P<0.05 ). (b) RNA 
quantification of  Nrf2 and HO-1 (d) from spleen of 3, 12, 23 months old 
rats. β-actin is used as  internal control (P<0.05 ). Black bars: F344 rat; Grey 
bars: HIV-1 TG rat. 
 
Since liver performs key metabolic functions, including anti-oxidation and 
detoxification and Nrf2 provide an essential contribution to these processes, 
we investigated its hepatic protein level in HIV-1 TG rat. Noticeably, elevated 
Nrf2 protein was observed at 3 months in HIV-TG rat despite the absence of 
increased concomitant RNA expression (Fig. 2a, 2b), suggesting that an 
enhanced rate of protein translation may occur in young animals to counteract 
the stress due to the presence of the HIV-1 transgene. With increasing age, the 
levels of Nrf2 protein decreased compared to the control animals and in the 
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liver of older HIV-1 TG animals, Nrf2 protein became undetectable (Fig. 
14a). Figure 14b shows that the Nrf2 RNA level in liver of 23 months-old 
HIV- 1 TG rat was higher than that of middle-aged rats. This result supports 
the idea that in the liver, Nrf2 protein degradation occurs more quickly during 
the aging process of HIV-TG rat, even with the increased production of RNA 
in 23 months-old compared to 12 months-old. To further verify whether the 
expression of HIV-1 transgene affects the expression of one of the key 
enzymes involved in the regulation of the liver antioxidant stress, we 
determined the age-related level of HO-1 between HIV-1 TG animals and 
their wild-type counterparts. As shown in Fig. 14c, HO-1 protein content was 
undetectable at 3 months in both experimental groups, while its level was 
markedly decreased in 12 months-old and at 23 months-old compared to F344 
animals. Interestingly, RNA level was subjected to a strong decrease in 
middle-aged HIV-1 TG rat, similarly to the protein level, and to an increase in 
the older age (Fig. 14d). Even considering that the rate of HO-1 protein 
synthesis may remain constant between 12 and 23 months-old in HIV-1 TG 
rat, the enhanced RNA content at 23 months-old may indicate an adaptive 
transcriptional response in counteracting the negative effects of HIV-1 
transgene. 
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Figure 14: Age-related expression of Nrf2 and HO-1 at protein and RNA levels in liver 
of HIV-1 TG and F344 rats. Western blot and densitometric analysis of total 
hepatic Nrf2 (a) and HO-1 (c) proteins from young, middleaged and aged group 
(P<0.05 ). (b) Nrf2 and HO-1 (d) RNA levels from 3, 12, 23 months old rats. β-
actin is used as internal control (P<0.05 ). Black bars: F344 rat; Grey bars: HIV-
1TG rat. 
 
4.3.4 Reduced Nrf2 and HO-1 protein levels in multiple brain 
areas of HIV-1 TG rat 
The pro-inflammatory and pro-oxidant effects of HIV-1 related proteins in the 
brain are well known. Therefore, we next investigated the in vivo impact of 
HIV-1 on the expression of Nrf2 in the brain, by measuring its levels in whole 
brain, cortex, cerebellum and hippocampus extracts. Our results indicate a 
substantial Nrf2 protein decrease in HIV-1 TG rat, particularly in the whole 
brain, cerebellum  
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and hippocampus at 23 months-old as well as in the cortex of middle-aged and 
older HIV-1 TG rat (Fig. 15b, 15c, 15d).  
 
 
Figure 15: Nrf2 protein levels in the brain of HIV-TG and F344 rats of varying ages. 
Western blot and densitometric analysis of total Nrf2 in whole-brain (a), 
cerebellum (b), cortex (c) and hippocampus (d) from 3, 12, 23 months old rats 
(P<0.05 ). Black bars: F344 rat; Grey bars: HIV-1 TG rat. 
 
The qRT-PCR quantification revealed differential Nrf2 RNA expression with 
age in all HIV-1 TG analysed brain regions with a tendency to increase at late 
age, (Fig. 16). 
 This observed RNA profile in HIV-1 TG animals may be a late 
transcriptional response to the presence of HIV-1 transgene.  
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Figure 16: RNA expression of Nrf2 in the brain. Nrf2 RNA in different brain regions: 
whole-brain (a), cerebellum (b), cortex (c) and hippocampus (d) from young, 
middle-aged and aged group (P<0.05 ). Black bars: F344 rat; Grey bars: HIV-1 
TG rat. 
 
For a more comprehensive evaluation, we next examined whether HO-1 
protein levels were negatively affected during aging in HIV-1TG rats. Results 
of the western blot assay showed that middle-aged and aged HIV-1 TG groups 
exhibited significantly lower HO-1 content than control F344 rats (Fig.17).  
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Figure 17: HO-1 protein levels in the brain of HIV-TG and F344 rats of varying ages. 
Western blot and densitometric analysis of HO-1 in whole-brain (a), cerebellum 
(b), cortex (c) and hippocampus (d) from 3, 12, 23 months old rats (P<0.05 ). 
Black bars: F344 rat; Grey bars: HIV-1TG rat. 
 
In addition, Fig. 18 indicates the RNA levels of HO-1 in various brain regions 
of HIV-TG rat; the data displayed different expression patterns, showing an 
increase in prevalence at 23 months-old. Taken together, the results provide 
compelling evidence that the chronic expression of HIV-1-related proteins 
causes defective protein expression of HO-1 and a shared transcriptional 
signature at 23 months-old among multiple brain areas. 
 
47 
 
 
Figure 18: RNA expression of HO-1 in the brain. HO-1 RNA in different brain regions: 
whole-brain (a), cerebellum (b), cortex (c) and hippocampus (d) from young, 
middle-aged and aged group (P<0.05 ). Black bars: F344 rat; Grey bars: HIV-1 
TG rat. 
 
4.3.5 SA-β-gal expression is enhanced in the HIV- 1 
TG rat 
 
Up to this point our data indicate that the oxidative state observed in the HIV-
1 rat might be linked to the agedependent reduction of Nrf2 and HO-1 
proteins. Considering that persistent oxidative stress promotes the occurrence 
of premature senescent phenotype, we next assessed SA-β-gal expression in 
HIV-1 TG rat. SA-β-gal positive tissue areas showed substantial increase in 
expression in 12 months-old HIV-1 TG rats with respect to age-matched F344 
animals (Fig. 19). As compared with the control, no considerable variation of 
SA-β-gal activity was found in spleen, liver and brain of young HIV-1 TG rat 
(data not shown). These results suggest that the declined protein function of 
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Nrf2 and HO-1 was accompanied by the acquisition of premature senescence 
phenotype in HIV-1 TG rat.  
 
 
Figure 19: Staining for senescence-associated-galactosidase (SA-β-gal) in HIV-1 TG and 
F344 rats. Representative staining from middle-aged group of (a) spleen F344 
rat; (b) spleen HIV-TG rat; (c) liver F344 rat; (d) liver HIV- 1 TG rat; (e) brain 
F344 rat; (f) brain HIV-1 TG rat. Magnification 10 x. Scale 100 μm. 
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5. DISCUSSION 
 
Recently, synergy assessment has become a key area in medicine research in 
order to enhance efficiency of treatments and affect not only one single target, 
but several targets. Numerous nutraceuticals have been found to target and 
attenuate the progression of age-related dysfunction (Prasain, 2010). 
Currently, there are a variety of dietary strategies to ameliorate mitochondrial 
function in ageing (Ferrari, 2004). Although resveratrol and equol have 
recently attracted scientific interest for a wide-ranging of health benefits, their 
influence on mitochondria is still poorly understood. Indeed, the first aim of 
the project was to investigate the effects of resveratrol and equol on 
mitochondrial biogenesis using the two compounds individually and in 
combination. Several studies were conducted showing the synergistic effect of 
resveratrol with different compounds (Csaki, 2009) but the combination with 
equol has never been tested on the mitochondrial function. The analysis of 
Mitotracker intensity showed that resveratrol induced an increase in 
mitochondrial mass compared to non-treated cells. Equol alone was not 
effective in terms of augmenting the mitochondrial mass, however the 
combined treatment (resveratrol + equol) was more effective respect to 
resveratrol alone. It is important to point out that mitochondrial dysfunction 
tend to induce a wide range of adaptations of nuclear gene expression, named 
the retrograde response (Butow, 2004). Typical of this adaptive process 
(mitohormesis) (Calabrese, 2012; Calabrese, 2007; Tapia, 2006)  is the up-
regulation of mitochondrial biogenesis (Biswas, 1999). A robust adaptive 
response may further explain the increase in mitochondrial mass. Moreover, It 
has been consistently demonstrated that activation of SIRT1 stimulates 
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mitochondrial biogenesis and resveratrol has been utilized as a SIRT1 
activator to regulate mitochondrial function (Lagouge, 2006). Since equol 
exhibits a wide range of biological properties, it may be a sirtuin-targeting 
nutraceutical to prevent mitochondrial decline. In this study, the combination 
of resveratrol with equol is associated with the activation of SIRT1. In 
addition, PGC1-α is a key component in modulating mitochondrial function 
and interacts with transcription factors such as NRF-1and TFAM. Our results 
indicate that these mitochondrial biogenesis factors were increased by 
combined treatment of resveratrol and equol. Collectively, these data 
demonstrate that the combination of two known natural products, resveratrol 
and equol exerts a synergistic effect on mitochondrial function because 
stimulates the mitochondrial biogenesis more than the single compounds 
alone. Clearly, more work is needed to provide novel insights into the 
mechanisms by which resveratrol and equol synergize to regulate the 
mitochondrial dynamics. However, the co-administration of these agents may 
be a possible nutraceutical and/or anti-ageing strategy for a number of 
mitochondria-associated disorders. 
 
Recently, a growing number of studies have indicated that the dietary 
antioxidants may be beneficial for neuronal recovery and survival in 
neurodegenerative disorders (Calabrese, 2009). Over the past years, the 
involvement of the HO-1 pathway in anti-degenerative mechanisms has 
received considerable attention (Piantadosi, 1997; Dorè, 2002). Notably, HO-
1 induction occurs together with the induction of other heat shock proteins 
during various physiopathological conditions, generating potent protective 
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system against brain oxidative injury (Calabrese, 2004). The second aim of 
the project was to provide evidence that the combination of EGCG and L-Car 
elicits two different pathways with synergistic neuroprotective effects and 
increasing viability of neuronal cells. Our results demonstrated that the 
neuroprotective effects of EGCG and L-Car are achieved through the 
targeting of HO-1/Hsp72 systems.  the effect of a combination of EGCG and 
L-Car was greater than the response achieved by the single compounds alone 
and over the expected additive effect of EGCG and L-Car. The synergistic 
action of these two agents supports the idea of a crosstalk between the HO-1 
and the Hsp72-mediated pathways which potentiates the efficacy of the two 
compounds used alone. Moreover, the hypothesis is further reinforced since 
we assumed that the cytoprotection obtained through the expression of Hsp72 
is less effective when HO-1 is blocked with its inhibitor ZnPP. Because of this 
crosstalk, combination of drugs activating the single pathways might have a 
more pronounced antioxidant effect in a number of physiopathological 
conditions where the sensing of redox status is imbalanced. These findings 
imply that HO-1/Hsp72 system might work as a promising therapeutic 
approach with potential for clinical usefulness. To our knowledge, this is the 
first time that the antioxidant activities of the selected natural agents EGCG 
and L-Car were investigated in combinations. Our study demonstrates that 
combined administration of EGCG and L-Car possesses a more apparent 
antioxidant activity compared with each of them alone. Therefore, our 
findings indicate that the synergistic antioxidant effects of EGCG and L-Car 
may be a successful approach in the prevention of brain aging. Finally this 
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study supports the promising therapeutic mechanism of EGCG and L-Car in 
protecting against oxidative stress related diseases. 
 
The third aim of the project was to characterize Nrf2/HO-1 pathway  in HIV-1 
TG rat. This pathway has received great nutritional interest since its 
cytoprotective effects are mainly modulated by dietary components. 
Moreover, there is a growing consensus that oxidative stress is a fundamental 
feature of HIV-1 infection (Uzasci, 2013) accompanied by disruption of the 
redox balance and decrease of the major antioxidant molecules (Gil, 2003). In 
the HAART era, numerous epidemiologic studies have provided critical 
evidence into the changing spectrum between the prevalence of AIDS and 
“non-AIDS” diseases (Blanco, 2010). Although HAART cannot be 
considered fully effective, the partial successful viral suppression caused an 
increase in the life expectancy but the deleterious consequences of HIV-1 
infection are shifted progressively toward frailty syndrome and age-related 
diseases (Ruiz, 2010). In this perspective, oxidative stress and constitutive 
production of inflammatory mediators due to the passive persistent presence 
of the virus plays an essential role in the onset of age-related diseases. 
However, only few studies have been focused on the potential protective 
function of Nrf2 against the pro-inflammatory state and oxidative injury 
during HIV-1 infection (Reddy, 2012). In the present study, we investigated 
the involvement of Nrf2 and its main antioxidant effector HO-1 in HIV-1 TG 
rat model. This non-infectious transgenic rat expresses all the HIV-1 viral 
genes except the gag–pol replication genes (Reid, 2001). Thus, studies 
conducted with HIV-1 TG rat provide valuable information about the acute 
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toxicity of viral proteins. These animals can be an useful model to simulate 
HIV-1 infection since they develop pathologies similar to humans infected 
with HIV-1 virus (Reid, 2001; Peng, 2010; Lashomb, 2009). Consistent with 
previous work (Reddy, 2012), our study demonstrates that the expression of 
HIV-1 related proteins may play a role in the inhibition of Nrf2 and HO-1 
protein expression with consequent limited ability to counteract the increased 
oxidative burden associated with HIV-1 infection. In addition, it was well 
established that Nrf2-deficient mice are more susceptible to oxidative stress 
(Yoh, 2008) and inflammatory disorders (Thimmulappa, 2006). Rao et al. 
reported that HIV-1 TG rat showed elevated markers of neuroinflammation in 
the brain (Rao, 2011). All these data and the clear synergism between HIV-1 
infection and aging (Önen, 2011) raise the intriguing possibility that HIV-1 
TG rat is a model to study “oxi-inflamm-aging” as this phenomenon was 
previously defined (De la Fuente, 2009; Franceschi, 2000). The general trend 
of down-regulation that we observed in Nrf2 and HO-1 protein levels may be 
due to HIV-1-related oxidative and nitrosative species that might lead to post-
translational deregulation and eventually faster degradation of Nrf2 and HO-1 
(Uzasci, 2013). In contrast, no consistent decline in the transcripts of Nrf2 and 
HO-1 was observed. Indeed, Nrf2 and HO-1 gene expression was not 
uniformly altered and it appeared differentially regulated in the tissues of 
HIV-1 TG rat. In some cases, we did not find substantial differences in gene 
expression. In other cases, we observed enhanced RNA content that may 
suggest an adaptive transcriptional activity in counteracting the negative 
effects of HIV-1 transgene. Finally, these changes in gene expression may not 
be affected by age in HIV-1 infected tissues. However, the regulation of Nrf2 
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expression and of its dependent genes can be achieved at multiple levels 
including transcriptional and post transcriptional events (Suh, 2004). 
Therefore, more studies are needed to further elucidate the crucial in vivo role 
of Nrf2 in the context of chronological aging in HIV-1. Recently, it has been 
reported that senescence is the result of accumulated oxidative injury 
(Barascu, 2012). SA-β-gal is a reliable marker of cellular senescence and it 
reflects the change in cell function that accompanies senescence (Campisi, 
2007). In our study, a marked increase of this senescence marker was 
observed in middle-aged HIV-1 TG animals compared to the controls and it is 
conceivable that deficiency of Nrf2/HO-1 proteins observed in the tissues may 
accentuate senescence during HIV-1infection. In summary, our findings have 
implications for understanding the involvement of the complex defense 
mechanism regulated by Nrf2 and HO-1 in response to HIV-1. The down-
regulation of these proteins is consistent with Salhan et al. observations that 
HIV-1 gene expression deactivates redox-sensitive stress response program in 
HIV-1 TG mice (Salhan, 2012). Despite a sustained induction of Nrf2 and 
HO-1 in presence of endogenous stresses, both persistent oxidative stress and 
reduction of Nrf2/HO-1 determined by HIV-1 may contribute to establish 
chronic inflammation and create favourable conditions for the replication of 
the virus. Dietary inducers of Nrf2 and HO-1 may provide a novel strategy for 
restoring this system and mitigate inflammation and oxidative stress during 
HIV-1 infection. 
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